Autopsy report · NCT01271049
An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
Cause of deathFunding or business
“Due to a business decision to stop the project, the study was terminated early.”
Life of this trial
- Ran for about 1 year 1 month before it stopped.
- 45 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Mondelēz International, Inc.
- Sponsor type
- Industry
- Conditions
- Helminthiasis
- Interventions
- Novel Food Product; Control Food Product
- Participants
- 45
- Sites
- 1
- Countries
- Brazil
Trials that died the same way
- Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
“Study was terminated due to a business decision to cancel the entire project.” - PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
“The study was terminated early due to company decision.” - Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
“The study was terminated due to a business decision.” - Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
“This study was terminated early due to company decision.” - Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
“Study was terminated early for strategic reasons. Only Part I of the study was completed.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.